Skip to main content
Clinical Trials/NCT02735746
NCT02735746CompletedNot Applicable

Novel High Fidelity Functional Lung Imaging in Adults Undergoing Radiation Therapy to Assess for Radiation Pneumonitis

Cedars-Sinai Medical Center1 site in 1 country60 target enrollmentStarted: August 21, 2016Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
60
Locations
1
Primary Endpoint
A Pearson correlation of >0.579 between peak expiratory flow as measured by HFFLI analysis of cinefluorograph compared with 4D planning CT

Study Overview

Brief Summary

The purpose of this study is to to compare lung function data generated by applying High Fidelity Functional Lung Imaging (HFFLI) software to 4D CT, cone beam CT, and fluoroscopic images of the lungs breathing to determine whether different modalities of imaging provide similar data on lung movement and function. HFFLI may detect changes in lung function in patients undergoing External Beam Radiotherapy for cancer.

Detailed Description

This study is designed to test a novel technology to examine early changes in the lung in hopes of identifying patients who may be at risk for radiation pneumonitis. Eligible subjects will undergo standard of care treatment with the use of the Varian TrueBeam system for radiation therapy of a cancer lesion in the chest. The imaging data acquired as part of usual standard of care for these patients is a pre-treatment 4D planning CT scan, and a daily cone beam CT at each radiation treatment visit. We will also obtain a series of images consisting of five six-second cinefluorographs (real time fluoroscopic movies, for a total each time of 30 seconds of fluoroscopy) of the lungs while the subject is breathing, each at precisely measured angles to the subject, on 4 different occasions. This study will compare lung function data generated by applying High Fidelity Functional Lung Imaging (HFFLI) software to 4D CT, cone beam CT, and fluoroscopic images of the lungs breathing to determine the degree of correlation between data generated from different imaging modalities. The study is open to adults over the age of 18, at any stage of cancer.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Adults 18 years and older
  • Prospective subjects will have been referred to Radiation Oncology for treatment requiring the use of the Varian TrueBeam system, for radiation therapy of a cancer lesion in the chest wall, lung, breast, or mediastinum in which the radiation field will include a portion of lung
  • The subject is able to understand the risks, benefits, and possible alternatives to participation in the study, and is able to give both written and verbal voluntary informed consent

Exclusion Criteria

  • For any reason, including pregnancy, subject is considered by the Investigator to be an unsuitable candidate or is put at excess risk by the study procedures.
  • Significant existing lung disease, not related to cancer as determined by the PI's review of the patient's PFTs.

Outcomes

Primary Outcomes

A Pearson correlation of >0.579 between peak expiratory flow as measured by HFFLI analysis of cinefluorograph compared with 4D planning CT

Time Frame: Baseline

A Pearson correlation of >0.579 between peak inspiratory flow as measured by HFFLI analysis of cinefluorograph compared with 4D planning CT

Time Frame: Baseline

A Pearson correlation of >0.579 between ventilation/local time constant as measured by HFFLI analysis of cinefluorograph compared with cone beam CT

Time Frame: During radiation therapy

As part of standard care, patients will have a cone beam CT on each day they receive radiation treatment. Treatment period varies.

A Pearson correlation of >0.579 between expiratory time constant as measured by HFFLI analysis of cinefluorograph compared with 4D planning CT

Time Frame: Baseline

A Pearson correlation of >0.579 between inspiratory time constant as measured by HFFLI analysis of cinefluorograph compared with 4D planning CT

Time Frame: Baseline

A Pearson correlation of >0.579 between tissue shear as measured by HFFLI analysis of cinefluorograph compared with cone beam CT

Time Frame: During radiation therapy

As part of standard care, patients will have a cone beam CT on each day they receive radiation treatment. Treatment period varies.

A Pearson correlation of >0.579 between ventilation/local time constant as measured by HFFLI analysis of cinefluorograph compared with 4D planning CT

Time Frame: Baseline

A Pearson correlation of >0.579 between tissue shear as measured by HFFLI analysis of cinefluorograph compared with 4D planning CT

Time Frame: Baseline

A Pearson correlation of >0.579 between peak expiratory flow as measured by HFFLI analysis of cinefluorograph compared with cone beam CT

Time Frame: During radiation therapy

As part of standard care, patients will have a cone beam CT on each day they receive radiation treatment. Treatment period varies.

A Pearson correlation of >0.579 between peak inspiratory flow as measured by HFFLI analysis of cinefluorograph compared with cone beam CT

Time Frame: During radiation therapy

As part of standard care, patients will have a cone beam CT on each day they receive radiation treatment. Treatment period varies.

A Pearson correlation of >0.579 between expiratory time constant as measured by HFFLI analysis of cinefluorograph compared with cone beam CT

Time Frame: During radiation therapy

As part of standard care, patients will have a cone beam CT on each day they receive radiation treatment. Treatment period varies.

A Pearson correlation of >0.579 between inspiratory time constant as measured by HFFLI analysis of cinefluorograph compared with cone beam CT

Time Frame: During radiation therapy

As part of standard care, patients will have a cone beam CT on each day they receive radiation treatment. Treatment period varies.

Secondary Outcomes

  • Total lung capacity(At 12 months post radiation)
  • Diffusing capacity for carbon monoxide(At 12 months post radiation)
  • FEV1/Forced vital capacity(At 12 months post radiation)
  • Forced expiratory volume 1 (FEV1)(At 12 months post radiation)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Stephen Shiao

Assistant Professor

Cedars-Sinai Medical Center

Study Sites (1)

Loading locations...

Similar Trials